Tabula Rasa HealthCare (TRHC) Trading Up 7.4%

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) shares were up 7.4% on Monday . The stock traded as high as $63.56 and last traded at $62.64. Approximately 994,776 shares were traded during mid-day trading, an increase of 139% from the average daily volume of 416,121 shares. The stock had previously closed at $58.33.

A number of research firms have commented on TRHC. BidaskClub lowered shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a report on Thursday, November 15th. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $80.00 target price on shares of Tabula Rasa HealthCare in a report on Thursday, December 6th. Zacks Investment Research raised shares of Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a report on Thursday, December 6th. Finally, Benchmark began coverage on shares of Tabula Rasa HealthCare in a report on Tuesday, January 8th. They set a “buy” rating and a $85.00 target price for the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $80.44.

Get Tabula Rasa HealthCare alerts:

The company has a current ratio of 0.49, a quick ratio of 0.46 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $1.32 billion, a P/E ratio of 180.50, a price-to-earnings-growth ratio of 3.68 and a beta of 1.79.

In other Tabula Rasa HealthCare news, CFO Brian W. Adams sold 1,316 shares of Tabula Rasa HealthCare stock in a transaction on Monday, January 28th. The shares were sold at an average price of $60.41, for a total transaction of $79,499.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Orsula V. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $57.02, for a total transaction of $456,160.00. The disclosure for this sale can be found here. Insiders have sold a total of 54,057 shares of company stock valued at $3,219,378 in the last ninety days. Company insiders own 14.00% of the company’s stock.

Several hedge funds have recently made changes to their positions in TRHC. Bank of New York Mellon Corp grew its holdings in shares of Tabula Rasa HealthCare by 34.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 214,062 shares of the company’s stock valued at $13,664,000 after buying an additional 54,507 shares during the period. Arizona State Retirement System grew its holdings in shares of Tabula Rasa HealthCare by 23.3% in the 3rd quarter. Arizona State Retirement System now owns 24,373 shares of the company’s stock valued at $1,979,000 after buying an additional 4,600 shares during the period. Chicago Equity Partners LLC grew its holdings in shares of Tabula Rasa HealthCare by 6.4% in the 3rd quarter. Chicago Equity Partners LLC now owns 15,050 shares of the company’s stock valued at $1,222,000 after buying an additional 900 shares during the period. Comerica Bank grew its holdings in shares of Tabula Rasa HealthCare by 12.5% in the 3rd quarter. Comerica Bank now owns 16,284 shares of the company’s stock valued at $1,313,000 after buying an additional 1,806 shares during the period. Finally, Wells Fargo & Company MN grew its holdings in shares of Tabula Rasa HealthCare by 673.0% in the 3rd quarter. Wells Fargo & Company MN now owns 187,511 shares of the company’s stock valued at $15,224,000 after buying an additional 163,255 shares during the period. 79.99% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This story was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/4219289/tabula-rasa-healthcare-trhc-trading-up-7-4.html.

Tabula Rasa HealthCare Company Profile (NASDAQ:TRHC)

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Further Reading: Why is cost of goods sold important?